Fennerty Mb

1.8k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Fennerty Mb is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Fennerty Mb has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Gastroenterology. Recurrent topics in Fennerty Mb's work include Gastric Cancer Management and Outcomes (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Esophageal Cancer Research and Treatment (7 papers). Fennerty Mb is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Esophageal Cancer Research and Treatment (7 papers). Fennerty Mb collaborates with scholars based in United States. Fennerty Mb's co-authors include Gary S. Bochna, Michael J. Shaw, John G. Lee, Robert V. Erickson, Joseph P. Moore, David J. Bjorkman, James A. DiSario, Michael E. Ryan, Carol Overby and Martin L. Freeman and has published in prestigious journals such as Gastroenterology, Gastrointestinal Endoscopy and Digestive Diseases and Sciences.

In The Last Decade

Fennerty Mb

24 papers receiving 1.2k citations

Hit Papers

Risk factors for post-ERCP pancreatitis: A prospective, m... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fennerty Mb United States 9 1.2k 1.0k 658 175 28 26 1.3k
JJB van Lanschot Netherlands 8 746 0.6× 921 0.9× 183 0.3× 588 3.4× 20 0.7× 14 1.2k
Masami Omae Japan 19 797 0.7× 1.0k 1.0× 138 0.2× 457 2.6× 39 1.4× 51 1.2k
Pieter Jan F. de Jonge Netherlands 12 858 0.7× 580 0.6× 153 0.2× 213 1.2× 15 0.5× 40 941
U Comin Italy 8 834 0.7× 795 0.8× 482 0.7× 106 0.6× 19 0.7× 14 938
Luca Lepre Italy 9 476 0.4× 340 0.3× 192 0.3× 42 0.2× 18 0.6× 50 605
Masaya Nakauchi Japan 19 505 0.4× 789 0.8× 179 0.3× 464 2.7× 12 0.4× 69 949
Jin Woong Cho South Korea 12 369 0.3× 412 0.4× 142 0.2× 259 1.5× 35 1.3× 30 559
Anil B. Nagar United States 12 340 0.3× 264 0.3× 242 0.4× 83 0.5× 28 1.0× 31 530
Peter H. Lisborg Austria 10 346 0.3× 342 0.3× 278 0.4× 124 0.7× 25 0.9× 20 590
Chi-Liang Cheng Taiwan 10 320 0.3× 260 0.3× 217 0.3× 127 0.7× 15 0.5× 16 418

Countries citing papers authored by Fennerty Mb

Since Specialization
Citations

This map shows the geographic impact of Fennerty Mb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fennerty Mb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fennerty Mb more than expected).

Fields of papers citing papers by Fennerty Mb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fennerty Mb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fennerty Mb. The network helps show where Fennerty Mb may publish in the future.

Co-authorship network of co-authors of Fennerty Mb

This figure shows the co-authorship network connecting the top 25 collaborators of Fennerty Mb. A scholar is included among the top collaborators of Fennerty Mb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fennerty Mb. Fennerty Mb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mb, Fennerty. (2005). Helicobacter pylori: why it still matters in 2005.. Cleveland Clinic Journal of Medicine. 72(Suppl_2). S1–S1. 20 indexed citations
2.
Mb, Fennerty. (2002). Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?. PubMed. 2 Suppl 2. S30–7. 7 indexed citations
3.
Sampliner, Richard E., Douglas O. Faigel, Fennerty Mb, et al.. (2001). Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: A multicenter study. Gastrointestinal Endoscopy. 53(6). 554–558. 93 indexed citations
4.
Freeman, Martin L., James A. DiSario, Douglas B. Nelson, et al.. (2001). Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointestinal Endoscopy. 54(4). 425–434. 883 indexed citations breakdown →
5.
Mb, Fennerty. (2000). New Therapy for Irritable Bowel Syndrome. Journal watch. 2000. 1 indexed citations
6.
Hahn, Martin, et al.. (2000). Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. Gastrointestinal Endoscopy. 52(1). 20–26. 26 indexed citations
7.
Pandolfino, John E., Peter J. Kahrilas, Kenneth R. DeVault, et al.. (2000). 3510 COMPARISON OF INTER- AND INTRA- OBSERVER CONSISTENCY OF ESOPHAGITIS GRADING BY EXPERT AND TRAINEE ENDOSCOPISTS.. Gastrointestinal Endoscopy. 51(4). AB112–AB112. 1 indexed citations
8.
Mb, Fennerty. (2000). Ablative therapies for Barrett's esophagus.. PubMed. 6(16 Suppl). S899–902. 1 indexed citations
9.
Knigge, Kandice, C J Kelly, Fennerty Mb, & W. Rich Peterson. (1998). A multicenter randomized trial with twice daily ranitidine bismuth-citrate (R), metronidazole (M) and tetracycline (T) for 7 or 10 days for eradication of H. pylori infection. Gastroenterology. 114. A180–A180. 1 indexed citations
11.
Laine, Loren, et al.. (1998). Prospective evaluation of the effect of proton pump inhibitor therapy on H. Pylori diagnostic testing. Gastroenterology. 114. A193–A193. 1 indexed citations
12.
Mb, Fennerty. (1997). Medical treatment of gastroesophageal reflux disease in the managed care environment.. PubMed. 8(2). 90–9. 16 indexed citations
13.
Mb, Fennerty, et al.. (1997). Little polyps: Are they a big problem?. Gastroenterology. 113(4). 1413–1414. 2 indexed citations
14.
Mb, Fennerty. (1996). Is a pound of prevention worth an ounce of cure?. Gastroenterology. 110(3). 958–962. 1 indexed citations
15.
Mb, Fennerty. (1996). Is the only good H. pylori a dead H. pylori?. Gastroenterology. 111(6). 1773–1774. 15 indexed citations
16.
Mb, Fennerty, et al.. (1995). Please, not another marker of cancer risk in Barrett's esophagus!. PubMed. 90(3). 511–2. 2 indexed citations
17.
Freeman, Martin L., Simon Sherman, William B. Silverman, et al.. (1995). Complications of endoscopic sphincterotomy in cirrhotics: A prospective multicenter study. Gastrointestinal Endoscopy. 41(4). 397–397. 6 indexed citations
18.
Mb, Fennerty, et al.. (1994). Two-year incidence of colon adenomas developing after tandem colonoscopy.. PubMed. 89(5). 687–91. 32 indexed citations
19.
Mb, Fennerty, et al.. (1993). Flow cytometry in Barrett's esophagus: when all is said and done, more is said than done!. PubMed. 88(2). 319–20. 3 indexed citations
20.
Mb, Fennerty, et al.. (1990). Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Digestive Diseases and Sciences. 35(1). 93–96. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026